Switching from interleukin-6 receptor inhibitors to the direct interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis: efficacy and safety during one year of therapy

P. A. Shesternya, A. A. Baranov, I. B. Vinogradova, O. N. Anoshenkova, O. V. Antipova, E. A. Bogdanova, Yu. Yu. Grabovetskaya, E. P. Ilivanova, A. N. Kalyagin, A. A. Blinova, N. A. Lapkina, M. V. Mokrousova, O. B. Nesmeyanova, N. M. Nikitina, N. V. Yudina, E. N. Alekseev, E. L. Nasonov, A. M. Lila

Open source

DOI: 10.14412/1996-7012-2024-5-54-64
Published: 2024-10-20
Container: Modern Rheumatology Journal
Publisher: IMA Press, LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.14412/1996-7012-2024-5-54-64,
  title = {Switching from interleukin-6 receptor inhibitors to the direct interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis: efficacy and safety during one year of therapy},
  author = {P. A. Shesternya and A. A. Baranov and I. B. Vinogradova and O. N. Anoshenkova and O. V. Antipova and E. A. Bogdanova and Yu. Yu. Grabovetskaya and E. P. Ilivanova and A. N. Kalyagin and A. A. Blinova and N. A. Lapkina and M. V. Mokrousova and O. B. Nesmeyanova and N. M. Nikitina and N. V. Yudina and E. N. Alekseev and E. L. Nasonov and A. M. Lila},
  year = {2024},
  journal = {Modern Rheumatology Journal},
  doi = {10.14412/1996-7012-2024-5-54-64},
  url = {https://doi.org/10.14412/1996-7012-2024-5-54-64}
}

RIS

TY  - JOUR
TI  - Switching from interleukin-6 receptor inhibitors to the direct interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis: efficacy and safety during one year of therapy
AU  - P. A. Shesternya
AU  - A. A. Baranov
AU  - I. B. Vinogradova
AU  - O. N. Anoshenkova
AU  - O. V. Antipova
AU  - E. A. Bogdanova
AU  - Yu. Yu. Grabovetskaya
AU  - E. P. Ilivanova
AU  - A. N. Kalyagin
AU  - A. A. Blinova
AU  - N. A. Lapkina
AU  - M. V. Mokrousova
AU  - O. B. Nesmeyanova
AU  - N. M. Nikitina
AU  - N. V. Yudina
AU  - E. N. Alekseev
AU  - E. L. Nasonov
AU  - A. M. Lila
PY  - 2024
JO  - Modern Rheumatology Journal
DO  - 10.14412/1996-7012-2024-5-54-64
UR  - https://doi.org/10.14412/1996-7012-2024-5-54-64
ER  -

APA

Shesternya, P. A., Baranov, A. A., Vinogradova, I. B., Anoshenkova, O. N., Antipova, O. V., Bogdanova, E. A., Grabovetskaya, Y. Y., Ilivanova, E. P., Kalyagin, A. N., Blinova, A. A., Lapkina, N. A., Mokrousova, M. V., Nesmeyanova, O. B., Nikitina, N. M., Yudina, N. V., Alekseev, E. N., Nasonov, E. L., & Lila, A. M. (2024). Switching from interleukin-6 receptor inhibitors to the direct interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis: efficacy and safety during one year of therapy. Modern Rheumatology Journal. https://doi.org/10.14412/1996-7012-2024-5-54-64

Source records

crossref · retrieved 2026-09-27T07:35:44.026Z